《半日速报》恒指半日收报28,342点 跌116点; 恒生科技指数半日收报7,847点 跌178点 京东健康跌逾7% 复星旅游文化、康宁杰瑞制药、神威药业、大新金融创新高
恒指半日收28,342点,跌116点或0.4%。恒生科技指数报7,847点,跌178点或2.2%。国指跌88点或0.8%,报10,614点。
活跃重磅股表现:
美团(03690.HK) 收268元,下跌2.6%;
阿里巴巴(09988.HK) 收205.2元,下跌1.3%;
港交所(00388.HK) 收449.8元,下跌0.8%;
腾讯(00700.HK) 收583.5元,下跌0.6%;
建行(00939.HK) 收6.19元,上升0.5%;
平安(02318.HK) 收81.25元,下跌0.2%;
友邦(01299.HK) 收101.6元,下跌0.1%;
异动恒指及国指成份股:
京东健康(06618.HK) 收110元,下跌7.1%;
翰森制药(03692.HK) 收33.3元,下跌4.9%;
碧桂园服务(06098.HK) 收80.9元,上升3.9%;
网易(09999.HK) 收179.9元,下跌3.9%;
华润啤酒(00291.HK) 收65.95元,下跌3.4%;
阿里健康(00241.HK) 收21.15元,下跌3.4%;
百度集团-SW(09888.HK) 收182.7元,下跌3.2%;
异动综合中小型股:
复星旅游文化(01992.HK) 收14.72元,上升10.5%,创新高;
康宁杰瑞制药(09966.HK) 收22.45元,上升4.4%,创新高;
神威药业(02877.HK) 收7.98元,上升3.5%,创新高;
大新金融(00440.HK) 收27.75元,上升2.2%,创新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.